Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis

BACKGROUND: Ewing sarcoma patients have a poor prognosis despite multimodal therapy. Integration of combination immunotherapeutic strategies into first-/second-line regimens represents promising treatment options, particularly for patients with intrinsic or acquired resistance to conventional therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghuis, Dagmar, Schilham, Marco W, Vos, Hanneke I, Santos, Susy J, Kloess, Stephan, Buddingh', Emilie P, Egeler, R Maarten, Hogendoorn, Pancras CW, Lankester, Arjan C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351702/
https://www.ncbi.nlm.nih.gov/pubmed/22587892
http://dx.doi.org/10.1186/2045-3329-2-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351702/
https://www.ncbi.nlm.nih.gov/pubmed/22587892
http://dx.doi.org/10.1186/2045-3329-2-8

Ejemplares similares